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OBJECTIVE — To determine the prevalence of diabetes and impaired fasting glucose (IFG)
and to assess clinical management indicators among adults with diabetes in a representative
sample of New York City adults.
RESEARCH DESIGN AND METHODS — In 2004, New York City implemented the
ﬁrst community-level Health and Nutrition Examination Survey (NYC HANES), modeled after
the National Health and Nutrition Examination Survey (NHANES). We used an interview to
determine previously diagnosed diabetes and measured fasting plasma glucose to determine
undiagnosed diabetes and IFG in a probability sample of 1,336 New York City adults. We
assessed glycemic control and other clinical indicators using standardized NHANES protocols.
RESULTS — The prevalence of diabetes among New York City adults was 12.5% (95% CI
10.3–15.1): 8.7% diagnosed and 3.8% undiagnosed. Nearly one-fourth (23.5%) of adults had
IFG. Asians had the highest prevalence of impaired glucose metabolism (diabetes 16.1%, IFG
32.4%)butweresigniﬁcantlylesslikelytobeobese.Amongadultswithdiagnoseddiabetes,less
thanone-half(45%)hadA1Clevels7%;one-half(50%)hadelevatedbloodpressuremeasures
at interview, 43% of whom were not on antihypertensive medications; nearly two-thirds (66%)
had elevated LDL levels, and only 10% had their glucose, blood pressure, and cholesterol all at
or below recommended levels. Most adults (84%) with diagnosed diabetes were on medication,
but only 12% were receiving insulin.
CONCLUSIONS — In New York City, diabetes and IFG are widespread. Policies and struc-
tural interventions to promote physical activity and healthy eating should be prioritized. Im-
proved disease management systems are needed for people with diabetes.
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N
ational surveillance has docu-
mented a sharp rise in diabetes
prevalence during the past 20 years
(1,2), including diabetes-related health
complications and mortality (3,4). Efforts
topreventandcontroldiabeteshavebeen
hamperedbyalackofsuccessatreducing
obesity, physical inactivity, smoking,
poor glycemic control, and other clinical
indicators such as high blood pressure
and cholesterol. Compared with the na-
tional average, urban communities typi-
callyhavealargerproportionofgroupsat
high risk for developing diabetes, includ-
ing black, Hispanic, and Asian residents
and those living in poverty (5,6). Yet, ef-
forts to monitor the diabetes epidemic in
urbansettingshavelargelybeenlimitedto
analyses of mortality and hospitalization
data, making it difﬁcult to discern patterns
of diabetes diagnosis, prevalence, and con-
trol, which are useful for guiding program-
matic efforts to curb the epidemic.
In New York City and other cities, ef-
forts are underway to improve diabetes
monitoring by measuring prevalence
through annual population-based tele-
phonesurveys,followingthemodelofthe
Behavioral Risk Factor Surveillance Sys-
tem (7). While self-reported diabetes sta-
tus can provide an informative and
ongoing measure of the local burden of
diagnosed diabetes, it cannot capture the
full spectrum of diabetes illness (missing
undiagnosed and unreported diabetes),
and it does not measure those at highest
risk of developing the condition or pro-
vide accurate information on glycemic
control or cardiovascular health among
those with diabetes.
In this study, we report ﬁndings from
the New York City Health and Nutrition
Examination Survey (NYC HANES), a
population-based interview and physical
exam survey conducted in 2004. By add-
ing an examination survey to existing
surveillance efforts, we estimated the
prevalenceofdiagnosedandundiagnosed
diabetes, as well as impaired fasting glu-
cose (IFG), among New York City adults.
We also examined glycemic control and
control of other cardiovascular risk fac-
tors to evaluate local diabetes manage-
ment efforts.
RESEARCH DESIGN AND
METHODS— NYC HANES was a
population-based, cross-sectional exami-
nation survey of noninstitutionalized
New York City residents aged 20 years or
older. Modeled after the National Health
and Nutrition Examination Survey
(NHANES)(8),NYCHANESusedacom-
parable three-stage probability sampling
to select a representative sample of adult
NewYorkersduringtheperiodfromJune
to December 2004. All noninstitutional-
ized New York City residents currently
living in a New York City household were
eligible to participate, including non-
English speakers, illiterate individuals,
pregnant women, and the mentally or de-
velopmentally disabled. Survey compo-
nentsconsistedofaphysicalexamination,
clinicalandlaboratorytests,aface-to-face
computer-assisted personal interview,
and an audio computer-assisted self-
interview. Interviews were pretranslated
intoEnglishandSpanish,andatranslator
was used for interviews conducted in
other languages. Detailed information on
data collection protocols and study de-
sign is published elsewhere (9).
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A household-based eligibility screening
survey was completed for 3,388 (84%) of
the 4,026 randomly selected households.
Within these households, 3,047 eligible
survey participants aged 20 years or older
were randomly selected based on an a
priori computer-generated sampling ﬂag,
1,999 of whom completed the face-to-
faceinterviewandatleastonecomponent
of the physical examination. Among
these, a random sample of participants
(80%) was assigned to fast for8ha n d
prioritized for a morning appointment.
Participantsself-identifyingwithahistory
of diabetes were not required to fast.
Adults not assigned to fast but who did so
voluntarily (n  136) were comparable
with those assigned to fast in all demo-
graphic characteristics except that age
and were included in the ﬁnal analytic
sample (n  1,336). The ﬁnal response
rate for this analysis was 53%.
Diabetes, IFG, and glycemic control
Participants were considered to have pre-
viously diagnosed diabetes if they re-
portedthatahealthcareprofessionalever
told them that they had diabetes, exclud-
ing gestational or borderline diabetes.
Participantswithoutapriordiabetesdiag-
nosis but whose fasting plasma glucose
level was 126 mg/dl were considered to
have undiagnosed diabetes (10). IFG, or
pre-diabetes, was deﬁned as a fasting
plasma glucose level of 100–125 mg/dl.
Glycemic control was measured by A1C,
with control deﬁned as A1C 7% (10).
Plasma glucose and A1C were tested at
the University of Missouri Diabetes Diag-
nostic Laboratory using standardized
NHANES methods (11).
Other measurements
All other measurements were taken using
standardized NHANES protocols and
deﬁnitions(8).Foreachparticipant,upto
four systolic/diastolic blood pressure
measurements were taken and the aver-
agewasreported,excludingtheﬁrstread-
ing and diastolic readings of zero. Lipid
proﬁles were analyzed at the Lipoprotein
Analytical Laboratory at Johns Hopkins
University Hospital. Current smoking
andphysicalinactivityweredeﬁnedusing
Healthy People 2010 guidelines (12).
Data analyses
Data were weighted to account for differ-
ential selection probabilities and survey
nonresponse; weights were poststratiﬁed
to the adult population of New York City
based on age-group, sex, race/ethnicity,
and borough as estimated by the 2004
American Community Survey and the
2004 March Supplement Current Popu-
lation Survey. Weights for participants
who voluntarily fasted (n  136) were
thenfurtheradjustedforobservedagedif-
ferences compared with participants ran-
domly assigned to fast. SUDAAN, version
9.0 (Research Triangle Institute, Research
Triangle Park, NC) was used to obtain SE
estimates by Taylor series linearization.
Diabetes and IFG prevalence estimates
were age adjusted to the 2000 U.S. stan-
dard population.
Diabetes (total, diagnosed, and undi-
agnosed), IFG, and diabetes control out-
comes were estimated by sex, age, race/
ethnicity, income, and nativity. Statistical
signiﬁcance for univariate differences in
prevalence was determined using the t
statistic derived from the general linear
contrastprocedure.RelativeSEsand95%
CIs were calculated for percentages. Esti-
mates with relative SEs of 30% were
considered unreliable (8). Two multiple
logistic regression models were also con-
structed to characterize diabetes preva-
lence as well as diabetes and IFG by race/
ethnicity and BMI, adjusting for sex, age,
nativity, income, and physical activity.
Adjusted prevalence estimates were ob-
tained using predicted marginals.
RESULTS
Prevalence of diabetes
The estimated total prevalence of diabetes
among New Yorkers aged 20 years or
olderwas12.5%,representing696,000
Table 1—Age-adjusted prevalence of diabetes, IFG, and normal glucose levels among New Yorkers >20 years of age (2004)
Diabetes IFG Normal Glucose
n % 95% CI % 95% CI % 95% CI
Total 1,336 12.5 10.3–15.1 23.5 20.9–26.2 64.0 61.1–66.9
Sex
Male (ref.) 561 13.4 10.0–17.7 29.6 25.2–34.3 57.1 52.2–61.8
Female 775 11.8 9.1–15.1 18.4*** 15.3–22.0 69.8*** 66.1–73.4
Age (years)
20–39 (ref.) 665 2.5 1.6–4.0 14.5 11.6–17.9 83.0 79.5–86.0
40–59 504 13.3*** 10.2–17.2 25.1*** 21.0–29.7 61.6*** 56.7–66.3
60 167 28.3*** 21.4–36.4 36.2*** 29.8–43.1 35.5*** 28.1–43.7
Race
a
White, non-Hispanic (ref.) 387 10.7 7.6–15.0 21.2 17.5–25.5 68.1 63.4–72.4
Black, non-Hispanic 290 14.5 9.9–20.7 21.5 16.3–27.8 64.0 57.8–69.7
Hispanic, total 479 12.3 8.7–17.2 25.2 20.5–30.6 62.4 57.1–67.5
Asian, non-Hispanic 160 16.1 9.5–25.9 32.4* 24.8–41.2 51.5*** 43.5–59.4
Income (USD)
b
$20,000 452 17.0** 13.3–21.5 21.6 17.8–26.0 61.4 56.8–65.8
$20,000 (ref.) 859 9.1 6.6–12.4 24.8 21.6–28.4 66.1 62.1–69.8
Nativity
U.S. born (ref.) 659 12.2 9.2–15.9 20.7 17.4–24.5 67.1 63.0–70.9
Foreign born 676 12.7 10.0–16.0 26.9* 23.3–30.7 60.4* 56.3–64.4
Sample includes 131 participants with diabetes, 278 with IFG, and 927 with normal fasting glucose.
aOther non-Hispanic ethnicities, not included due to small
numbers and unreliability of estimate; total with diabetes, n  20.
bTotals do not equal 1,336 because of missing data. *P  0.05, **P  0.01, ***P  0.001.
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lence increased with age, from 2.5%
among adults aged 20–39 years
to 28.3% among adults aged 60 years
or older (P  0.001), but did not differ
signiﬁcantly by sex, race/ethnicity, or na-
tivity. Diabetes prevalence was higher
among those with family incomes less
than $20,000 than among those with
higher family incomes (17.0 vs. 9.1%,
P  0.002).
The prevalence of diagnosed diabetes
was 8.7% (95% CI 6.8–11.2) and undi-
agnosed diabetes 3.8% (2.6–5.4), indi-
cating that nearly one-third (30.4%) of
adults with diabetes were undiagnosed
(Fig.1).BlacksandAsianshadthehighest
prevalence of diagnosed diabetes (12.1
and 11.4%, respectively), and the rate of
diagnosed diabetes was signiﬁcantly
higher among blacks than whites (P 
0.04). Adults aged 60 years or older had
signiﬁcantly higher rates of both diag-
nosed and undiagnosed diabetes than
other age-groups.
IFG
The prevalence of IFG among adults was
23.5% (Table 1) and increased with age,
affecting more than one-third (36.2%) of
adults aged 60 years or older. Men had
higherlevelsofIFGthanwomen(29.6vs.
18.4%, P  0.0003). IFG was highest in
Asians (32.4%)—higher than in whites
(P  0.02) or blacks (P  0.03). Foreign-
born adults were more likely to have IFG
than those born in the U.S. (26.9 vs.
20.7%, P  0.02). Among foreign-born
adults, IFG levels were elevated in both
foreign-born Asians (32.7%, P  0.02)
and foreign-born Hispanics (30.3%, P 
0.03) compared with foreign-born whites
(19.6%).
In multivariate models, there were
signiﬁcantdifferencesinlevelsofdiabetes
by race and BMI (Fig. 2A). After adjusting
for other factors, a higher proportion of
Asians and blacks with normal weight
had diabetes than whites (8.3 and 7.6%
vs.1.0%,respectively,P0.05).Ageand
income remained positively associated
with diabetes. Low-income adults were
more likely to have diabetes than higher-
incomeadults(15.7vs.8.9%,P0.006).
Disparities between normal-weight Asians
and other races/ethnicities were even
more striking (1.5–2 times higher) when
modeling levels of diabetes and IFG
(Fig. 2B).
Cardiovascular disease risk factors
Cardiovascular disease–related clinical
indicators important for diabetes man-
agement for adults with diabetes, IFG,
and normal glucose levels are presented
inTable2.Morethanone-half(55.1%)of
adults with diagnosed diabetes had A1C
7%, and 17.1% had A1C 9%. A total
of 12.3% of adults with diagnosed diabe-
tes were on insulin (with or without oral
agents), 71.5% were on oral agents only,
and16.1%werenottakingdiabetesmed-
ications. Among those with A1C levels
9% (n  18), only 15.8% were taking
insulin.
More than two-thirds (69.7%) of
adultswithdiagnoseddiabeteswereiden-
tiﬁed as hypertensive, and one-half
(50.0%) had elevated blood pressure
measures at interview. Of those with di-
agnosed diabetes and elevated blood
pressure, 43.1% were not on antihyper-
tensive medications and 35.4% were un-
diagnosed for hypertension. Similarly,
nearly two-thirds of adults with diag-
nosed diabetes had elevated LDL levels
(65.7%), of whom three-fourths (72.6%)
were not taking cholesterol-lowering
medications and 42.8% were undiag-
nosed for hypercholesterolemia. Overall,
Figure 1—Prevalence of diagnosed and undiagnosed diabetes among New Yorkers aged 20 years and older: NYC HANES 2004.
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betes had glucose, blood pressure, and
cholesterol all at recommended levels.
Morethanoneinﬁve(22.2%)adultswith
diagnosed diabetes reported being a cur-
rent smoker.
Adults with diagnosed diabetes were
more likely to have A1C levels 7% than
thosewithundiagnoseddiabetes(55.1vs.
30.4%, P  0.01). Otherwise, cardio-
vascular disease risk factors were similar
between the two groups. Compared with
adults with either IFG or normal glucose
levels,adultswithdiagnoseddiabeteshad
higher rates of high blood pressure.
CONCLUSIONS — This study docu-
ments a high prevalence of diabetes
among New York City adults and quanti-
ﬁes the even larger proportion of adults
with pre-diabetes. Our ﬁndings suggest
that more than one-third of adult New
Yorkers have abnormal glucose metabo-
lisms, placing them at elevated risk for
cardiovascular disease and death (3,13).
These results underscore the need for com-
prehensivepoliciesandprogramstoreduce
obesityanddiabetes.Foradultswithdiabe-
tes, detection of disease and control of its
complications were poor. Nearly one-third
of New York City adults with the disease
remain unrecognized. Among those with
diagnoseddiabetes,widespreadglucoseim-
pairment and poor control of blood pres-
sure and cholesterol suggest pervasive
failures in clinical management.
The prevalence of diabetes measured
in this survey (12.5%) was signiﬁcantly
higher than the published national
NHANES estimate of 9.3% (95% CI
8.39–10.23) from 1999 to 2002, using
the same methods, labs, and standards
(1).Thisobserveddifferenceisunlikelyto
be explained by subsequent increases in
national prevalence through 2004; an-
nual monitoring of self-reported diabetes
amongNewYorkCityresidentsshoweda
17% increase between 2002 and 2004,
whereas comparable national diabetes
rates did not increase signiﬁcantly (14).
Thehighconcentrationofpovertyandra-
cial/ethnic diversity in New York City
most likely contributes to its higher prev-
alence of diabetes.
AnevenlargergroupofadultsinNew
York City had IFG, although levels were
comparable with national estimates (24
vs.26%)(1).StudieshaveshownthatIFG
increasesriskofcardiovasculardiseaseby
30% (3,13) and is linked to higher all-
cause and cardiovascular disease mortal-
ity(4).WefoundthatadultswithIFGhad
asigniﬁcantlyhigherfrequencyofcardio-
vascular risk factors than adults with nor-
mal glucose levels. Among people at high
riskfordevelopingdiabetes,diseaseman-
agement through lifestyle changes, such
as diet and exercise, has been shown to
Figure 2—Adjusted prevalence (predicted marginals) for diabetes (A) and diabetes and IFG (B)
by BMI category and race/ethnicity. Both models control for sex, age, place of birth, income, and
physical activity. A:
aEstimate is higher than that for whites at P  0.05. B:
aEstimate is higher
than those for all other normal-weight racial/ethnic groups at P  0.05.
bEstimate is higher than
that for overweight whites at P  0.05.
cEstimate is higher than that for overweight whites (P
0.001)andHispanics(P0.05).
dEstimateishigherthanthatforobeseblacksatP0.05.Non
Hisp, non-Hispanic.
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(15).
The pervasiveness of elevated glucose
levels suggests that policies aimed at
changing the built and food environ-
ments are needed to make it easier for
peopletobemorephysicallyactiveandto
eat smaller, healthier amounts. In local
jurisdictions,suchchangesmightinclude
decreasing the price of fruits and vegeta-
bles or expanding sales outlets, reducing
the availability of calorie-dense snack
foods, developing bicycle paths or jog-
ging trails, or increasing safety protection
on streets, parks, and playgrounds. With-
out a national commitment to change the
built and food environments, however,
the impact of such local initiatives is
limited.
Unlike its national counterpart
(NHANES), NYC HANES included
enough Asians to estimate diabetes and
IFG levels in this group. In doing so, we
found that they had the highest levels of
glucose impairment of any race/ethnicity,
withnearlyone-halfhavingglucoselevels
above the normal range. Among those in
the normal-weight range, Asians had
higher levels of diabetes even after adjust-
ing for other demographic factors. These
ﬁndings support previous studies that
identiﬁedhigherdiabetesriskinAsiansat
lower BMI levels than whites, particularly
among South Asians (16,17). Despite
lower BMIs, Asians are almost twice as
likely to have diabetes as whites (17), re-
sulting in higher rates of cardiovascular
disease and death (18,19). While obesity
isanimportantscreeningmarkerformost
racial/ethnic groups, lower BMI cutoffs
for assessing risk have been recom-
mended for Asian patients (16).
Over one-half of New Yorkers with
diagnosed diabetes had poorly controlled
blood glucose levels, suggesting inade-
quate disease management and lack of
aggressive medication therapy. The pro-
portion of New York City adults with
diagnosed diabetes not taking any med-
ications was similar to national rates, but
the proportion taking insulin was strik-
ingly low (12%): only half as frequent as
among adults with diabetes nationally
(23%) (20). Among those at highest risk
forcomplications(adultswithA1C9%)
most were not taking insulin. Traditional
approaches to diabetes treatment have
followed a stepwise introduction of non-
pharmacologic approaches, followed by
oral agents and, ﬁnally, insulin. More re-
cent recommendations are that oral
agents should be started in conjunction
with lifestyle modiﬁcation as ﬁrst-line
treatment, rather than waiting for non-
pharmacologic approaches to take effect,
andthatinsulintherapyshouldbestarted
early in patients not meeting target glyce-
mic goals (21). Our ﬁndings suggest that
providers in New York City should con-
sider insulin therapy earlier in the course
of their patients’ disease.
Among those with diagnosed diabe-
tes,mosthadelevatedbloodpressureand
LDL cholesterol levels, and medication
usewasfarfromoptimal.Giventhatheart
disease and stroke account for the major-
ityofdiabetes-relateddeaths,agreaterfo-
cus on improving the routine use of these
medications is critical. Disease manage-
ment programs that monitor treatment
indicators and patient adherence to med-
ication and improve access to low-cost
medications can improve treatment rates
(22).
More than 80% of New Yorkers diag-
nosed with diabetes were overweight or
obese, and one-third reported no leisure-
time physical activity, both of which are
far below current recommendations (23).
Bothweightreductionandphysicalactiv-
ityarestronglyassociatedwithpreventing
and mitigating the effects of diabetes, hy-
pertension, and hypercholesterolemia
(15). Similarly, these data suggest that
smoking prevalence is high among adults
withbothdiagnosedandundiagnoseddi-
abetes. Programs designed to address
these behaviors will not only have a pos-
itive effect on overall health status of
adults with diabetes but also a preventive
impactamongthoseatriskfordeveloping
the disease.
In New York City, recent efforts to
improve diabetes management include
improved public health surveillance, as
well as patient, provider, and public edu-
cation. In 2006, the New York City De-
partment of Health and Mental Hygiene
implemented the New York City A1C
Registry. The registry is a combined sur-
veillance system and intervention in
which clinical labs report A1C test results
electronically. The information is used to
create decision-support tools and re-
sourcesforprovidersandtheirpatientsto
improve awareness and glycemic control.
NYCHANESdataaresubjecttosev-
eral limitations, including recall bias
and measurement error in the examina-
tion components, but the study strictly
adhered to widely accepted quality-
assurance procedures from NHANES
protocols. Also, the small sample size
limited more detailed analyses that
might have resulted in a better under-
standing of diabetes in speciﬁc sub-
Table 2—Cardiovascular disease risk factors among people with diagnosed and undiagnosed diabetes, IFG, and normal glucose levels
Diagnosed diabetes Undiagnosed diabetes IFG Normal fasting glucose
n % 95% CI n % 95% CI n % 95% CI n % 95% CI
Cardiovascular disease
risk factors
High A1C ( 7%) 51 55.1*† 43.20–66.47 13 30.4*† 17.68–46.96 3 0.9
a 0.28–3.15 1 0.1
a 0.01–0.73
High total cholesterol
(200 mg/dl) 46 47.2 35.23–59.41 18 51.1 32.72–69.24 141 53.9* 47.95–59.77 343 39.3 35.67–43.09
High LDL cholesterol
(100 mg/dl) 59 65.7 52.17–77.04 22 63.6 44.20–79.36 207 78.9* 72.61–84.14 569 65.3 61.45–68.96
High blood pressure
(systolic 130 or
diastolic 80) 41 50.0* 38.78–61.23 18 50.9‡ 33.53–68.06 101 41.0* 34.53–47.73 173 22.0 18.83–25.47
Current smoker 22 22.2 14.78–32.02 15 32.3 18.22–50.59 72 23.0 18.34–28.40 234 24.8 21.47–28.47
Impaired fasting glucose is deﬁned as a fasting plasma glucose level between 100 and 125 mg/dl.
aStatistically unstable population estimate. Using normal glucose
as the referent group: *P  0.001, ‡P  0.01. Using impaired fasting glucose as the referent group: †P  0.001.
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55% was suboptimal, post-stratiﬁcation
weighting based on age-group, sex, race/
ethnicity, and borough was applied to
minimizetheimpactofnonresponsebias.
Nationally and in New York City, a
disturbing proportion of adults with dia-
betes are unaware of their condition
and/or are undertreated for it, increasing
the risk of serious health complications.
The levels of documented comorbid con-
ditions also remain alarmingly high, de-
spite being amenable to public health
interventions. The large reservoir of New
Yorkers with IFG suggests that diabetes
prevalence will continue to grow in the
years to come, amplifying these current
problems even further. Effective pro-
grams to prevent progression to diabetes
should be expanded.
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